Sitemap
December 05, 2009 Articles
Filter by Available Specialty
- Adding bortezomib, thalidomide to standard multiple myeloma treatments improved response in older patients
- Advanced care planning helped patients with hematologic malignancies cope
- Bendamustine/rituximab superior to CHOP-rituximab regimen in several NHLs
- COG P9407 trial: MLL partner genes identified, linked to outcomes
- Omacetaxine may be viable treatment option for patients with T315I-positive CML
- Optimal dose of JAK inhibitor demonstrated benefits in patients with myelofibrosis
- Participation in an international consortium reduced APL mortality in developing countries